High expression of CD23 in the proliferation centers of splenic and nodal chronic lymphocytic leukemia.

被引：0
|
作者：
Lampert, IA [1 ]
Wotherspoon, A [1 ]
Van Noorden, S [1 ]
Hasserjian, RP [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
825
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [21] THE 2 CD23 ISOFORMS DISPLAY DIFFERENTIAL REGULATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    FOURNIER, S
    YANG, LP
    DELESPESSE, G
    RUBIO, M
    BIRON, G
    SARFATI, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) : 373 - 379
  • [22] Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia
    Saka, B
    Aktan, M
    Sami, U
    Oner, D
    Sanem, O
    Dinçol, G
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 30 - 35
  • [23] CD23 quantification in chronic lymphocytic leukemia and the effects of anti-CD23 therapy on its levels.
    Jilani, I
    O'Brien, S
    Kantarjian, H
    Caiyo, J
    Giles, F
    Ferrajoli, A
    Keating, M
    Albitar, M
    BLOOD, 2003, 102 (11) : 361B - 361B
  • [24] BCL-2/CD23 co-expression: A marker for B-Cell chronic lymphocytic leukemia
    Mehta, KU
    Abdel-Malik, AS
    Greenberg, S
    Ferreira, P
    Ray, D
    Sharon, D
    CYTOMETRY, 2000, 42 (05): : 312 - 312
  • [25] Soluble CD23 measurement by CBA: A convenient and reliable quantification method in chronic lymphocytic leukemia
    Grelier, A.
    Le Garff-Tavernier, M.
    Nauwelaers, F.
    Sarfati, M.
    Merle-Beral, H.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2014, 86 (02) : 91 - 97
  • [26] Level of CD20 expression and disease activity in chronic lymphocytic leukemia.
    Benke, SM
    Sheridan, D
    BLOOD, 2003, 102 (11) : 226B - 226B
  • [27] Prognostic importance of CD49d expression in chronic lymphocytic leukemia.
    Shanafelt, Tait D.
    Bone, Nancy D.
    Geyer, Susan M.
    LaPlant, Betsy
    Witzig, Thomas E.
    Schwager, Susan
    Dewald, Gordon W.
    Nowakowski, Greg S.
    Tschumper, Renee C.
    Zent, Clive S.
    Call, Timothy G.
    Jelinek, Diane F.
    Kay, Neil E.
    BLOOD, 2006, 108 (11) : 786A - 786A
  • [28] SERUM SOLUBLE CD23 (SCD23) IS A PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    SARFATI, M
    BIRON, G
    LELEUX, A
    JACQUY, C
    PAESMANS, M
    STRYCKMANS, P
    FONTEYN, C
    ARMANT, M
    DELESPESSE, G
    BRON, D
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
  • [29] Combined effect of increased serum levels of beta-2 microglobulin and soluble CD23 in B-cell chronic lymphocytic leukemia.
    Molica, S
    Levato, D
    Cascavilla, N
    DellOlio, M
    Dattilo, A
    Mannella, A
    Matera, R
    Musto, P
    BLOOD, 1997, 90 (10) : 2330 - 2330
  • [30] High dose Rituximab in chronic lymphocytic leukemia.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    BLOOD, 2003, 102 (11) : 359B - 360B
12345